Literature DB >> 19902311

Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients.

Yoshihiro Sakamoto1, Kazuaki Shimada, Satoshi Nara, Minoru Esaki, Hidenori Ojima, Tsuyoshi Sano, Junji Yamamoto, Tomoo Kosuge.   

Abstract

BACKGROUND: Optical surgical management of infrahilar/suprapancreatic cholangiocarcinoma remains controversial.
METHODS: Between 1988 and 2006, 77 patients with infrahilar/suprapancreatic cholangiocarcinoma underwent curative surgical resections following our intention-to-treat strategy. The clinicopathological factors affecting survival were evaluated using univariate and multivariate analyses with regard to the surgical procedures and surgical margins.
RESULTS: The surgical procedure included extrahepatic bile duct resection alone (EHBD; n = 17), major hepatectomy combined with extrahepatic bile duct resection (MHx; n = 26), pancreaticoduodenectomy (PD; n = 28), and MHx and concomitant PD (HPD; n = 6). Performance of MHx and/or PD in addition to EHBD increased surgical morbidity (p = 0.001). Among patients undergoing the four surgical procedures (EHBD, MHx, PD, and HPD), no significant difference was found in the incidence of positive overall surgical margins (53%, 65%, 46%, and 67%, p = 0.51) or long-term survivals (median survival time, 51, 27, 41, and 22 months, p = 0.60). A multivariate analysis revealed that perineural invasion (95% confidence interval, 1.1-12.3, p = 0.009), nodal metastasis (1.6-6.8, p = 0.001), and blood transfusion (1.1-3.9, p = 0.02) were independent predictors of a poor outcome. Perineural invasion was associated with positive radial margins (p = 0.045) and submucosal ductal infiltration (p = 0.03).
CONCLUSION: Perineural invasion, rather than the type of surgical procedure, had a significant impact on surgical curability and survival of patients with infrahilar/suprapancreatic cholangiocarcinoma treated according to our intention-to-treat strategy.

Entities:  

Mesh:

Year:  2009        PMID: 19902311     DOI: 10.1007/s11605-009-1072-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  36 in total

1.  Outcome of treatment for distal bile duct cancer.

Authors:  Y Fong; L H Blumgart; E Lin; J G Fortner; M F Brennan
Journal:  Br J Surg       Date:  1996-12       Impact factor: 6.939

2.  Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer.

Authors:  Yoshihiro Sakamoto; Tomoo Kosuge; Kazuaki Shimada; Tsuyoshi Sano; Taizo Hibi; Junji Yamamoto; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  J Surg Oncol       Date:  2006-09-15       Impact factor: 3.454

3.  Intraoperative transfusion: is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy?

Authors:  Sang-Jae Park; Sun-Whe Kim; Jin-Young Jang; Kuhn-Uk Lee; Yong-Hyun Park
Journal:  World J Surg       Date:  2002-02-04       Impact factor: 3.352

4.  Clinicopathologic studies on perineural invasion of bile duct carcinoma.

Authors:  M R Bhuiya; Y Nimura; J Kamiya; S Kondo; S Fukata; N Hayakawa; S Shionoya
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

5.  Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer.

Authors:  Takanori Yoshida; Toshifumi Matsumoto; Atsushi Sasaki; Yuji Morii; Masanori Aramaki; Seigo Kitano
Journal:  Arch Surg       Date:  2002-01

6.  Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey.

Authors:  R Reding; J L Buard; G Lebeau; B Launois
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

7.  Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells.

Authors:  M A Blajchman; L Bardossy; R Carmen; A Sastry; D P Singal
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

8.  Blood transfusion and disease-free survival in carcinoma of the breast.

Authors:  M M Nowak; J L Ponsky
Journal:  J Surg Oncol       Date:  1984-10       Impact factor: 3.454

9.  Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  J Yamamoto; T Kosuge; T Takayama; K Shimada; S Yamasaki; H Ozaki; N Yamaguchi; S Mizuno; M Makuuchi
Journal:  Surgery       Date:  1994-03       Impact factor: 3.982

10.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02
View more
  12 in total

1.  Isolated caudate lobectomy with pancreatoduodenectomy for a bile duct cancer.

Authors:  Tsuyoshi Sano; Yasuhiro Shimizu; Yoshiki Senda; Koji Komori; Seiji Ito; Tetsuya Abe; Taira Kinoshita; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2013-09-13       Impact factor: 3.445

2.  Surgical strategy for bile duct cancer: Advances and current limitations.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Daijo Hashimoto
Journal:  World J Clin Oncol       Date:  2011-02-10

3.  Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy.

Authors:  Yuji Kaneoka; Akihiro Yamaguchi; Masatoshi Isogai; Takashi Kumada
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

4.  The Impact of MDCT and Endoscopic Transpapillary Mapping Biopsy to Predict Longitudinal Spread of Extrahepatic Cholangiocarcinoma.

Authors:  Kyoji Ito; Yoshihiro Sakamoto; Hiroyuki Isayama; Yosuke Nakai; Takeyuki Watadani; Mariko Tanaka; Tetsuo Ushiku; Nobuhisa Akamatsu; Junichi Kaneko; Junichi Arita; Kiyoshi Hasegawa; Norihiro Kokudo
Journal:  J Gastrointest Surg       Date:  2018-05-15       Impact factor: 3.452

5.  The Likely Sites of Nodal Metastasis Differs According to the Tumor Extent in Distal Bile Duct Cancer.

Authors:  Yuichiro Kato; Shinichiro Takahashi; Naoto Gotohda; Masaru Konishi
Journal:  J Gastrointest Surg       Date:  2016-06-02       Impact factor: 3.452

6.  Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin.

Authors:  In Woong Han; Jin-Young Jang; Kyoung Bun Lee; Mee Joo Kang; Wooil Kwon; Jae Woo Park; Ye Rim Chang; Sun-Whe Kim
Journal:  HPB (Oxford)       Date:  2013-12-06       Impact factor: 3.647

7.  Survival benefits of surgical resection in recurrent cholangiocarcinoma.

Authors:  Sun Choon Song; Jin Seok Heo; Dong Wook Choi; Seong Ho Choi; Woo Seok Kim; Min Jung Kim
Journal:  J Korean Surg Soc       Date:  2011-09-26

8.  Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.

Authors:  Keun Soo Ahn; Koo Jeong Kang; Yu Na Kang; Yong Hoon Kim; Tae-Seok Kim
Journal:  BMC Gastroenterol       Date:  2016-02-24       Impact factor: 3.067

Review 9.  Red blood cell transfusions and the survival in patients with cancer undergoing curative surgery: a systematic review and meta-analysis.

Authors:  Fausto Petrelli; Michele Ghidini; Antonio Ghidini; Giovanni Sgroi; Ivano Vavassori; Daniela Petrò; Mary Cabiddu; Alberto Aiolfi; Gianluca Bonitta; Alberto Zaniboni; Emanuele Rausa
Journal:  Surg Today       Date:  2021-01-03       Impact factor: 2.549

Review 10.  Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinoma.

Authors:  Anna Strongin; Harkirat Singh; Mohamad A Eloubeidi; Ali A Siddiqui
Journal:  Endosc Ultrasound       Date:  2013-04       Impact factor: 5.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.